Physician profile
Guy L Peterson
NPI 1790097798
$2,031.70
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.13 · 2020: $305 · 2021: $336 · 2022: $392 · 2023: $563 · 2024: $269 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,035.52 | 2020-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Next Science LLC | $183.93 | 2023 | Blastx, Xperience, Surgx |
| Smith+Nephew, INC. | $162.55 | 2020-2025 | Collagenase Santyl |
| Acera Surgical, INC. | $150.29 | 2022 | |
| Kerecis Limited | $143.38 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $117.40 | 2020-2023 | V.A.C.Ulta, Activ.A.C., 3m Cavilon |
| Reapplix INC. | $95.13 | 2024-2025 | 3c Patch Kit - Box |
| La Jolla Pharmaceutical Company | $43.13 | 2019 | |
| Medline Industries LP | $26.53 | 2020-2022 | |
| Convatec INC. | $24.30 | 2020-2022 | |
| Integra Lifesciences Corporation | $18.13 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.00 | 2023 | Xarelto |
| Cashflow Solutions, LLC | $14.41 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.